In an in vitro study conducted by Liu et al., the efficacy of mesenchymal stem cells (MSCs) genetically modified to express HGF, utilizing an adenovirus vector, was investigated as a therapeutic intervention for PD [300]. This evidence concerns the gene HGF and Parkinson disease.